TY - JOUR T1 - The Impact of Face-Masks on Total Mortality Heterogenous Effects by Gender and Age JF - medRxiv DO - 10.1101/2021.06.08.21258545 SP - 2021.06.08.21258545 AU - Giacomo De Giorgi AU - Maria Maddalena Speziali AU - Felix Michalik Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/06/12/2021.06.08.21258545.abstract N2 - Governments around the world have been implementing several non-pharmaceutical interventions (NPIs) to fight Covid-19 spread and its associated mortality. We estimate the causal impact of mandatory face-mask wearing policy in public places on (total) mortality in Switzerland. We exploit the staggered introduction of the policy across Swiss cantons using a Difference-in-Difference and an event study approach. We find that the extension of compulsory mask wearing to public places has an heterogeneous impact on mortality, with small positive effects on male mortality entirely driven by older age-cohorts (90+). Finally, we show that adding contact tracing and stricter distancing to compulsory face-mask policy does not lead to better results in terms of mortality.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding to acknowledge for this project.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:use of publicly available secondary aggregate data. anonymous data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData all fully publicly available and we provide all the guidelines to download those data from the Swiss National Statistical Office. ER -